Mezzion Pharma Co., Ltd.
Develops novel therapeutics for rare diseases, focusing on Fontan circulation.
140410 | KO
Overview
Corporate Details
- ISIN(s):
- KR7140410002
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 강남구 삼성로 570 석천빌딩 7층, 서울특별시
- Website:
- https://mezzion.com
- Sector:
- Manufacturing
Description
Mezzion Pharma Co., Ltd. is an innovation-driven pharmaceutical company focused on discovering, developing, and commercializing novel therapeutics for rare diseases. The company's primary efforts are concentrated on addressing the unmet medical needs of individuals with a Fontan circulation, a palliative surgical procedure for single-ventricle heart defects. Its lead drug candidate, udenafil, is being advanced as a potential first-to-market treatment to improve the physiology of the Fontan circulation. Mezzion is conducting late-stage clinical development, including a confirmatory Phase 3 trial (FUEL-2), to evaluate the therapy's efficacy in adolescent patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-03-16 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 11.4 KB | ||
| 2023-03-16 00:00 |
주주총회집중일개최사유신고
|
Korean | 5.3 KB | ||
| 2023-02-22 00:00 |
[기재정정]주식매수선택권부여에관한신고
|
Korean | 26.9 KB | ||
| 2023-02-22 00:00 |
[기재정정]주식매수선택권부여에관한신고
|
Korean | 27.1 KB | ||
| 2023-02-22 00:00 |
[기재정정]주식매수선택권부여에관한신고
|
Korean | 27.7 KB | ||
| 2023-02-21 00:00 |
[기재정정]투자판단관련주요경영사항(폰탄환자치료제 유데나필의 임상3상(추가 임상) 임상시험계획 신청)
|
Korean | 13.1 KB | ||
| 2023-02-20 00:00 |
투자판단관련주요경영사항(폰탄환자치료제 유데나필의 임상3상(추가 임상) 임상시험계획 신청)
|
Korean | 9.8 KB | ||
| 2022-12-15 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.2 KB | ||
| 2022-11-11 00:00 |
분기보고서 (2022.09)
|
Korean | 891.6 KB | ||
| 2022-08-12 00:00 |
반기보고서 (2022.06)
|
Korean | 911.4 KB | ||
| 2022-07-11 00:00 |
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 8.6 KB | ||
| 2022-07-01 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.5 KB | ||
| 2022-07-01 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.5 KB | ||
| 2022-07-01 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.5 KB | ||
| 2022-07-01 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.5 KB |
Automate Your Workflow. Get a real-time feed of all Mezzion Pharma Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Mezzion Pharma Co., Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Mezzion Pharma Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
